Home / RX.V : TSXV

AI Analysis Fundamentals Valuation Video Analysis Similar

AI Analysis

How does RX.V make money? Does RX.V have pricing power? What's the Earnings Whisper? Will RX.V profit more as the business scales? What is RX.V's management track record? Is RX.V's current price justified?

BioSyent Inc.

CAD 15.85 +$3.09 (+24.22%)

TSXV · 14 Sep 2026 19:59 UTC

Previous Close

CAD 15.66

Day Range

CAD 15.65CAD 15.98

Year Range

CAD 10.65CAD 16.25

Market Cap

181.3M

AVG Volume

10.16K

Trailing/Forward PE

18.01/14.81

PEG ratio

2.57

Dividend Yield

1.36%

Next Earnings Date

2026-11-19

Primary Exchange

Toronto Stock Exchange Ventures

Revenue (CAD)

RX.V Revenue (CAD) by year
Period	Revenue (CAD)
2025	43.05M
2024	35.03M
2023	31.59M
2022	27.93M
2021	28.62M
2020	22.33M
2019	21.42M
2018	21.53M
2017	20.76M
2016	17.92M

Net Income (CAD)

RX.V Net Income (CAD) by year
Period	Net Income (CAD)
2025	9.01M
2024	7.27M
2023	6.46M
2022	5.46M
2021	6.28M
2020	3.8M
2019	4.37M
2018	5.71M
2017	5.21M
2016	4.31M

Operating Income (CAD)

RX.V Operating Income (CAD) by year
Period	Operating Income (CAD)
2025	11.36M
2024	8.75M
2023	7.45M
2022	6.98M
2021	8.18M
2020	3.16M
2019	5.39M
2018	6.79M
2017	6.83M
2016	5.75M

EBITDA (CAD)

RX.V EBITDA (CAD) by year
Period	EBITDA (CAD)
2025	12.83M
2024	10.1M
2023	8.48M
2022	7.48M
2021	8.68M
2020	5.71M
2019	6.19M
2018	6.99M
2017	7M
2016	5.9M

Cash Flows (CAD)

RX.V Cash Flows (CAD) by year
Period	Cash Flows (CAD)
2025	8.95M
2024	4.25M
2023	2.53M
2022	4.43M
2021	4.58M
2020	6.72M
2019	4.19M
2018	5.78M
2017	5.91M
2016	3.99M

EPS (CAD)

RX.V EPS (CAD) by year
Period	EPS (CAD)
2025	0.79
2024	0.62
2023	0.54
2022	0.45
2021	0.49
2020	0.29
2019	0.32
2018	0.4
2017	0.36
2016	0.3

Expenses (CAD)

RX.V Expenses (CAD) by year
Period	Expenses (CAD)
2025	20.72M
2024	22.51M
2023	20.08M
2022	16.02M
2021	14.03M
2020	11.99M
2019	11.5M
2018	10.32M
2017	9.97M
2016	8.78M

Cash & Debt (CAD)

RX.V Cash & Debt (CAD) by year
Period	Cash & Debt (CAD)
2025	28.65M
2024	15.94M
2023	26.19M
2022	28.7M
2021	28.21M
2020	25.58M
2019	21.97M
2018	24.43M
2017	19.34M
2016	13.74M

Debt ratios

RX.V Debt ratios by year
Period	Debt ratios
2025	-0.72
2024	-0.43
2023	-0.82
2022	-0.97
2021	-0.97
2020	-0.92
2019	-0.77
2018	-0.98

Margins

RX.V Margins by year
Period	Margins
2025	76.04%
2024	79.19%
2023	80.65%
2022	81.85%
2021	79.1%
2020	78.02%
2019	77.7%
2018	76.99%
2017	76.94%
2016	78.82%

Return on Capital

RX.V Return on Capital by year
Period	Return on Capital
2025	21.73%
2024	20.77%
2023	18.59%
2022	16.36%
2021	19.91%
2020	14.16%
2019	16.94%
2018	20.67%
2017	23.44%
2016	25.76%

Shares Outstanding

RX.V Shares Outstanding by year
Period	Shares Outstanding
2025	11.26M
2024	11.28M
2023	11.74M
2022	12.1M
2021	12.47M
2020	12.79M
2019	13.45M
2018	14.38M
2017	14.51M
2016	14.4M

Dividends (CAD)

RX.V Dividends (CAD) by year
Period	Dividends (CAD)
2026	0.17
2025	0.2
2024	0.18
2023	0.16
2022	0.04

Book Value Per Share (CAD)

RX.V Book Value Per Share (CAD) by year
Period	Book Value Per Share (CAD)
2025	3.68
2024	3.1
2023	2.96
2022	2.76
2021	2.53
2020	2.1
2019	1.92
2018	1.92
2017	1.53
2016	1.16

Total Assets (CAD)

RX.V Total Assets (CAD) by year
Period	Total Assets (CAD)
2025	49.44M
2024	41.36M
2023	41.53M
2022	40.49M
2021	37.17M
2020	33.57M
2019	30.97M
2018	31.19M
2017	25.1M
2016	19.25M

PE Ratio

RX.V PE Ratio by year
Period	PE Ratio
Sep 26	19.88
Sep 26	19.64
Sep 26	20.03
Aug 26	19.76
Aug 26	19.69
Aug 26	19.13
Aug 26	18.82
Jul 26	18.5
Jul 26	18.49
Jul 26	18.19
Jul 26	18.31
Jul 26	18.19
Jun 26	17.56
Jun 26	17.43
Jun 26	17.36
Jun 26	17.12
May 26	17.45
May 26	17.12
May 26	18.05
May 26	18.37
May 26	17.88
Apr 26	18.43
Apr 26	18.5
Apr 26	19.06
Apr 26	18.58
Mar 26	19.17
Mar 26	20.02
Mar 26	20.48
Mar 26	20.48
Feb 26	20.59
Feb 26	19.58
Feb 26	19.47
Feb 26	16.69
Jan 26	16.43
Jan 26	17.28
Jan 26	16.89
Jan 26	16.79
Jan 26	16.64
Dec 25	17.44
Dec 25	16.69
Dec 25	16.15
Dec 25	16.6
Nov 25	16.54
Nov 25	14.66
Nov 25	14.99
Nov 25	14.95
Oct 25	14.99
Oct 25	15.26
Oct 25	14.99
Oct 25	15.74
Oct 25	16.32
Sep 25	16.94
Sep 25	16.86
Sep 25	17.03
Sep 25	17.04
Aug 25	17.39
Aug 25	17.3
Aug 25	16.43
Aug 25	16.43
Aug 25	16.4
Jul 25	16.83
Jul 25	16.5
Jul 25	17
Jul 25	17.26
Jun 25	18.3
Jun 25	18.16
Jun 25	18.48
Jun 25	18.54
May 25	18.31
May 25	18.54
May 25	18.23
May 25	16.84
May 25	16.99
Apr 25	16.29
Apr 25	16.29
Apr 25	16.08
Apr 25	15.36
Mar 25	18.18
Mar 25	18.42
Mar 25	18.26
Mar 25	17.8
Feb 25	18.26
Feb 25	18.08
Feb 25	17.93
Feb 25	18.1
Jan 25	17.93
Jan 25	18.05
Jan 25	17.75
Jan 25	18.21
Jan 25	18.19
Dec 24	18.81
Dec 24	19.04
Dec 24	19.42
Dec 24	18.4
Nov 24	18.26
Nov 24	18.24
Nov 24	17.93
Nov 24	18.08
Nov 24	18.53
Oct 24	18.45

Free Cash Flow Yield

RX.V Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	7.06%
Sep 26	7.15%
Sep 26	7.01%
Aug 26	7.11%
Aug 26	7.13%
Aug 26	7.34%
Aug 26	7.46%
Jul 26	7.59%
Jul 26	7.59%
Jul 26	7.72%
Jul 26	7.67%
Jul 26	7.72%
Jun 26	5.66%
Jun 26	5.7%
Jun 26	5.72%
Jun 26	5.8%
May 26	5.69%
May 26	5.8%
May 26	5.51%
May 26	5.41%
May 26	5.56%
Apr 26	5.39%
Apr 26	5.37%
Apr 26	5.21%
Apr 26	5.35%
Mar 26	4.69%
Mar 26	4.49%
Mar 26	4.39%
Mar 26	4.39%
Feb 26	4.36%
Feb 26	4.59%
Feb 26	4.61%
Feb 26	5.38%
Jan 26	5.47%
Jan 26	5.2%
Jan 26	5.32%
Jan 26	5.35%
Jan 26	5.4%
Dec 25	5.02%
Dec 25	5.24%
Dec 25	5.42%
Dec 25	5.27%
Nov 25	5.29%
Nov 25	5.97%
Nov 25	5.84%
Nov 25	5.85%
Oct 25	5.84%
Oct 25	5.73%
Oct 25	5.84%
Oct 25	5.56%
Oct 25	5.36%
Sep 25	1.64%
Sep 25	1.65%
Sep 25	1.63%
Sep 25	1.63%
Aug 25	1.6%
Aug 25	1.61%
Aug 25	1.69%
Aug 25	1.69%
Aug 25	1.69%
Jul 25	1.65%
Jul 25	1.68%
Jul 25	1.63%
Jul 25	1.61%
Jun 25	3.19%
Jun 25	3.22%
Jun 25	3.16%
Jun 25	3.15%
May 25	3.19%
May 25	3.15%
May 25	3.2%
May 25	3.47%
May 25	3.44%
Apr 25	3.59%
Apr 25	3.59%
Apr 25	3.63%
Apr 25	3.8%
Mar 25	-0.07%
Mar 25	-0.07%
Mar 25	-0.07%
Mar 25	-0.07%
Feb 25	-0.07%
Feb 25	-0.07%
Feb 25	-0.07%
Feb 25	-0.07%
Jan 25	-0.07%
Jan 25	-0.07%
Jan 25	-0.07%
Jan 25	-0.07%
Jan 25	-0.07%
Dec 24	0.22%
Dec 24	0.22%
Dec 24	0.22%
Dec 24	0.23%
Nov 24	0.23%
Nov 24	0.23%
Nov 24	0.23%
Nov 24	0.23%
Nov 24	0.23%
Oct 24	0.23%

Price to Sales

RX.V Price to Sales by year
Period	Price to Sales
Sep 26	3.91
Sep 26	3.86
Sep 26	3.94
Aug 26	3.88
Aug 26	3.87
Aug 26	3.76
Aug 26	3.7
Jul 26	3.64
Jul 26	3.63
Jul 26	3.57
Jul 26	3.6
Jul 26	3.57
Jun 26	3.68
Jun 26	3.65
Jun 26	3.63
Jun 26	3.58
May 26	3.65
May 26	3.58
May 26	3.78
May 26	3.85
May 26	3.74
Apr 26	3.86
Apr 26	3.87
Apr 26	3.99
Apr 26	3.89
Mar 26	3.92
Mar 26	4.1
Mar 26	4.19
Mar 26	4.19
Feb 26	4.22
Feb 26	4.01
Feb 26	3.99
Feb 26	3.42
Jan 26	3.36
Jan 26	3.54
Jan 26	3.46
Jan 26	3.44
Jan 26	3.41
Dec 25	3.65
Dec 25	3.49
Dec 25	3.38
Dec 25	3.47
Nov 25	3.46
Nov 25	3.06
Nov 25	3.13
Nov 25	3.12
Oct 25	3.13
Oct 25	3.19
Oct 25	3.13
Oct 25	3.29
Oct 25	3.41
Sep 25	3.46
Sep 25	3.44
Sep 25	3.48
Sep 25	3.48
Aug 25	3.55
Aug 25	3.54
Aug 25	3.36
Aug 25	3.36
Aug 25	3.35
Jul 25	3.44
Jul 25	3.37
Jul 25	3.47
Jul 25	3.53
Jun 25	3.8
Jun 25	3.77
Jun 25	3.84
Jun 25	3.85
May 25	3.8
May 25	3.85
May 25	3.78
May 25	3.49
May 25	3.53
Apr 25	3.38
Apr 25	3.38
Apr 25	3.34
Apr 25	3.19
Mar 25	3.74
Mar 25	3.79
Mar 25	3.76
Mar 25	3.67
Feb 25	3.76
Feb 25	3.72
Feb 25	3.69
Feb 25	3.73
Jan 25	3.69
Jan 25	3.72
Jan 25	3.66
Jan 25	3.75
Jan 25	3.75
Dec 24	3.98
Dec 24	4.02
Dec 24	4.11
Dec 24	3.89
Nov 24	3.86
Nov 24	3.86
Nov 24	3.79
Nov 24	3.82
Nov 24	3.92
Oct 24	3.9

EV/EBITDA

RX.V EV/EBITDA by year
Period	EV/EBITDA
Sep 26	13.27
Sep 26	13.11
Sep 26	13.37
Aug 26	13.18
Aug 26	13.14
Aug 26	12.75
Aug 26	12.54
Jul 26	12.32
Jul 26	12.31
Jul 26	12.1
Jul 26	12.19
Jul 26	12.1
Jun 26	10.17
Jun 26	10.08
Jun 26	10.03
Jun 26	9.86
May 26	10.09
May 26	9.86
May 26	10.51
May 26	10.74
May 26	10.39
Apr 26	10.78
Apr 26	10.82
Apr 26	11.22
Apr 26	10.89
Mar 26	11.25
Mar 26	11.82
Mar 26	12.13
Mar 26	12.13
Feb 26	12.21
Feb 26	11.52
Feb 26	11.45
Feb 26	9.56
Jan 26	9.39
Jan 26	9.96
Jan 26	9.7
Jan 26	9.63
Jan 26	9.53
Dec 25	10.42
Dec 25	9.9
Dec 25	9.53
Dec 25	9.84
Nov 25	9.8
Nov 25	8.5
Nov 25	8.73
Nov 25	8.7
Oct 25	8.73
Oct 25	8.92
Oct 25	8.73
Oct 25	9.25
Oct 25	9.65
Sep 25	10.3
Sep 25	10.24
Sep 25	10.36
Sep 25	10.37
Aug 25	10.61
Aug 25	10.55
Aug 25	9.94
Aug 25	9.94
Aug 25	9.92
Jul 25	10.22
Jul 25	9.99
Jul 25	10.34
Jul 25	10.52
Jun 25	11.7
Jun 25	11.6
Jun 25	11.83
Jun 25	11.87
May 25	11.71
May 25	11.87
May 25	11.65
May 25	10.65
May 25	10.76
Apr 25	10.25
Apr 25	10.25
Apr 25	10.1
Apr 25	9.58
Mar 25	11.81
Mar 25	11.99
Mar 25	11.87
Mar 25	11.53
Feb 25	11.87
Feb 25	11.73
Feb 25	11.62
Feb 25	11.75
Jan 25	11.62
Jan 25	11.71
Jan 25	11.49
Jan 25	11.83
Jan 25	11.82
Dec 24	12.6
Dec 24	12.77
Dec 24	13.07
Dec 24	12.29
Nov 24	12.18
Nov 24	12.17
Nov 24	11.93
Nov 24	12.04
Nov 24	12.39
Oct 24	12.33

Price/Operating Cashflow

RX.V Price/Operating Cashflow by year
Period	Price/Operating Cashflow
Sep 26	13.81
Sep 26	13.64
Sep 26	13.91
Aug 26	13.72
Aug 26	13.68
Aug 26	13.29
Aug 26	13.07
Jul 26	12.85
Jul 26	12.84
Jul 26	12.63
Jul 26	12.72
Jul 26	12.63
Jun 26	16.94
Jun 26	16.82
Jun 26	16.75
Jun 26	16.52
May 26	16.83
May 26	16.52
May 26	17.41
May 26	17.73
May 26	17.26
Apr 26	17.79
Apr 26	17.85
Apr 26	18.39
Apr 26	17.93
Mar 26	20.34
Mar 26	21.24
Mar 26	21.72
Mar 26	21.72
Feb 26	21.84
Feb 26	20.77
Feb 26	20.66
Feb 26	17.71
Jan 26	17.43
Jan 26	18.33
Jan 26	17.92
Jan 26	17.81
Jan 26	17.65
Dec 25	12.03
Dec 25	11.52
Dec 25	11.14
Dec 25	11.45
Nov 25	11.41
Nov 25	10.12
Nov 25	10.34
Nov 25	10.31
Oct 25	10.34
Oct 25	10.53
Oct 25	10.34
Oct 25	10.86
Oct 25	11.26
Sep 25	18.96
Sep 25	18.86
Sep 25	19.06
Sep 25	19.07
Aug 25	19.46
Aug 25	19.36
Aug 25	18.38
Aug 25	18.38
Aug 25	18.35
Jul 25	18.83
Jul 25	18.46
Jul 25	19.03
Jul 25	19.32
Jun 25	14.8
Jun 25	14.69
Jun 25	14.95
Jun 25	15
May 25	14.81
May 25	15
May 25	14.75
May 25	13.62
May 25	13.75
Apr 25	13.18
Apr 25	13.18
Apr 25	13.01
Apr 25	12.43
Mar 25	17.97
Mar 25	18.21
Mar 25	18.05
Mar 25	17.59
Feb 25	18.05
Feb 25	17.87
Feb 25	17.72
Feb 25	17.88
Jan 25	17.72
Jan 25	17.84
Jan 25	17.55
Jan 25	18
Jan 25	17.98
Dec 24	44.85
Dec 24	45.39
Dec 24	46.32
Dec 24	43.88
Nov 24	43.53
Nov 24	43.49
Nov 24	42.76
Nov 24	43.11
Nov 24	44.19
Oct 24	44

Price to Book

RX.V Price to Book by year
Period	Price to Book
Sep 26	3.99
Sep 26	3.95
Sep 26	4.02
Aug 26	3.97
Aug 26	3.96
Aug 26	3.84
Aug 26	3.78
Jul 26	3.72
Jul 26	3.71
Jul 26	3.65
Jul 26	3.68
Jul 26	3.65
Jun 26	3.82
Jun 26	3.79
Jun 26	3.77
Jun 26	3.72
May 26	3.79
May 26	3.72
May 26	3.92
May 26	3.99
May 26	3.89
Apr 26	4.01
Apr 26	4.02
Apr 26	4.14
Apr 26	4.04
Mar 26	4.15
Mar 26	4.33
Mar 26	4.43
Mar 26	4.43
Feb 26	4.46
Feb 26	4.24
Feb 26	4.21
Feb 26	3.61
Jan 26	3.56
Jan 26	3.74
Jan 26	3.65
Jan 26	3.63
Jan 26	3.6
Dec 25	3.83
Dec 25	3.67
Dec 25	3.55
Dec 25	3.65
Nov 25	3.63
Nov 25	3.22
Nov 25	3.29
Nov 25	3.28
Oct 25	3.29
Oct 25	3.35
Oct 25	3.29
Oct 25	3.46
Oct 25	3.59
Sep 25	3.68
Sep 25	3.66
Sep 25	3.7
Sep 25	3.7
Aug 25	3.78
Aug 25	3.76
Aug 25	3.57
Aug 25	3.57
Aug 25	3.56
Jul 25	3.66
Jul 25	3.58
Jul 25	3.69
Jul 25	3.75
Jun 25	3.8
Jun 25	3.77
Jun 25	3.84
Jun 25	3.85
May 25	3.8
May 25	3.85
May 25	3.79
May 25	3.5
May 25	3.53
Apr 25	3.38
Apr 25	3.38
Apr 25	3.34
Apr 25	3.19
Mar 25	3.46
Mar 25	3.51
Mar 25	3.48
Mar 25	3.39
Feb 25	3.48
Feb 25	3.44
Feb 25	3.41
Feb 25	3.44
Jan 25	3.41
Jan 25	3.43
Jan 25	3.38
Jan 25	3.47
Jan 25	3.46
Dec 24	3.8
Dec 24	3.84
Dec 24	3.92
Dec 24	3.72
Nov 24	3.69
Nov 24	3.68
Nov 24	3.62
Nov 24	3.65
Nov 24	3.74
Oct 24	3.73

No video analysis for this stock yet. Request one from our team.

AI Analysis

BioSyent Inc.

Video analysis: RX.V

Similar companies